SEC Comment Letter for DarioHealth Corp. (DRIO) (CIK 0001533998) (DRIO) — May 14, 2018
DarioHealth Corp. (DRIO) (CIK 0001533998)
Date: May 14, 2018 · CIK: 0001533998 · Accession: 0000000000-18-014846
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-224458
Letter
Mail Stop 3030 May 1 4, 2018 Via E -mail Erez Raphael Chief Executive Officer DarioHealth Corp. 8 HaTokhen Street Caesarea Industrial Park 3088900, Israel
Re: DarioHealth Corp. Registration Statement on Form S-3 Filed April 26, 2018 File No. 333-224458
Dear Mr. Raphael :
This is to advise you that we have not reviewed and will not review your registration statement .
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Caleb French at (202) 551 -6947 with any questions.
Sincerely,
/s/ Caleb French for
Show Raw Text
Mail Stop 3030 May 1 4, 2018 Via E -mail Erez Raphael Chief Executive Officer DarioHealth Corp. 8 HaTokhen Street Caesarea Industrial Park 3088900, Israel Re: DarioHealth Corp. Registration Statement on Form S-3 Filed April 26, 2018 File No. 333-224458 Dear Mr. Raphael : This is to advise you that we have not reviewed and will not review your registration statement . Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Caleb French at (202) 551 -6947 with any questions. Sincerely, /s/ Caleb French for Amanda Ravitz Assistant Director Office of Electronics and Machinery cc: Robert V. Condon III, Esq. Sullivan & Worcester LLP